Coeptis Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COEP and other ETFs, options, and stocks.About COEP
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments.
CEODavid Mehalick
CEODavid Mehalick
Employees7
Employees7
HeadquartersWexford, Pennsylvania
HeadquartersWexford, Pennsylvania
Founded2017
Founded2017
Employees7
Employees7
COEP Key Statistics
Market cap78.02M
Market cap78.02M
Price-Earnings ratio-3.71
Price-Earnings ratio-3.71
Dividend yield—
Dividend yield—
Average volume131.68K
Average volume131.68K
High today$14.81
High today$14.81
Low today$14.01
Low today$14.01
Open price$14.67
Open price$14.67
Volume193.59K
Volume193.59K
52 Week high$21.41
52 Week high$21.41
52 Week low$2.31
52 Week low$2.31
Stock Snapshot
The current Coeptis Therapeutics(COEP) stock price is $14.66, with a market capitalization of 78.02M. The stock trades at a price-to-earnings (P/E) ratio of -3.71.
On 2025-12-20, Coeptis Therapeutics(COEP) stock traded between a low of $14.01 and a high of $14.81. Shares are currently priced at $14.66, which is +4.6% above the low and -1.0% below the high.
The Coeptis Therapeutics(COEP)'s current trading volume is 193.59K, compared to an average daily volume of 131.68K.
During the past year, Coeptis Therapeutics(COEP) stock moved between $2.31 at its lowest and $21.41 at its peak.
During the past year, Coeptis Therapeutics(COEP) stock moved between $2.31 at its lowest and $21.41 at its peak.
People also own
Based on the portfolios of people who own COEP. This list is generated using Robinhood data, and it’s not a recommendation.